SUN-LB135 Estrogen Receptor Beta Inhibits NFkB Signaling to Inhibit Triple Negative Breast Cancer

Triple Negative Breast Cancer (TNBC) affects approximately 15-20% of BC patients, yet accounts for a disproportionately higher rate of BC morbidity and mortality, in part due to lack of targeted therapies. We have shown that estrogen receptor beta (ERβ) is expressed in approximately 20% of TN breast...

Descripción completa

Detalles Bibliográficos
Autores principales: Aspros, Kirsten, Subramaniam, Malayannan, Ye, Zhenqing, Sun, Zhifu, Ingle, James, Goetz, Matthew, Hawse, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Steroid Hormones and Receptors
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208680/
http://dx.doi.org/10.1210/jendso/bvaa046.2252

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208680/
http://dx.doi.org/10.1210/jendso/bvaa046.2252

Ejemplares similares